SKIN SARCOIDOSIS: CLINICAL VARIANTS AND PROGNOSTIC SIGNIFICANCE
- Authors: Kirdakov D.F.1, Fomin V.V.1, Potekaev N.N.1, Kirdakov DF1, Fomin VV1, Potekaev NN1
-
Affiliations:
- Issue: No 18 (2011)
- Pages: 28-33
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279084
- ID: 279084
Cite item
Full Text
Abstract
About the authors
Dmitriy Fedorovich Kirdakov
Viktor Viktorovich Fomin
Nikolay Nikolaevich Potekaev
D F Kirdakov
V V Fomin
N N Potekaev
References
- Collin B, Rajaratnam R, Lim R, et al. A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department. Clin Exp Dermatol 2009;35(2):131-34.
- Коган Е.А., Корнев Б.М., Попова Е.Н. и др. Интерстициальные болезни легких / под. ред. Н.А. Мухина. М., 2007. С. 120-44.
- Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M.tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997;156:1000-03.
- Goldberg HJ, Fiedler D, Webb A, et al. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 2006;100(11):2063-68.
- Dal Sacco D, Cozzani E, Parodi A, Rebora A. Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol 2005;44(5):411-12.
- Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med 2008;14(5):434-39.
- Morais A, Alves H, Lima B, et al. HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients. Rev Port Pneumol 2008;14(6):727-46.
- Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73:720-35.
- Berlin M, Fogdell-Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-05.
- Amoli MM, Thomson W, Hajeer AH, et al. HLA-DRB1 associations in biopsy proven erythema nodosum. J Rheumatol 2001;28(12):2660-62.
- Amoli MM, Donn RP, Thomson W, et al. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002;29(8):1671-73.
- Amoli MM, Lopez-Agreda H, Suarez-Amor O, et al. Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. Clin Exp Rheumatol 2007;25(4):624-26.
- Mrazek F, Holla LI, Hutyrova B, et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005;65(2):163-71.
- Labunski S, Posern G, Ludwig S, et al. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001;81(1):18-21.
- Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008;151(2):251-59.
- McDougal KE, Fallin MD, Moller DR, et al.; ACCESS Research Group. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol 2009;129(8):1921-6.
- Amoli MM, Llorca J, Gomez-Gigirey A, et al. E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Clin Exp Rheumatol 2004;22:230-2.
- Hamblin AS, Shakoor Z, Kapahi P, Haskard D. Circulating adhesion molecules in sarcoidosis. Clin Exp Immunol 1994;96(2):335-8.
- Berlin M, Lundahl J, Skold CM, et al. The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum. J Intern Med 1998;244(4):333-40.
- Judson MA, Baughman RP, Thompson BW, et al.; ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003;20(3):204-11.
- Okamoto H, Mizuno K, Ohtoshi E. Cutaneous sarcoidosis with cardiac involvement. Eur J Dermatol 1999;9(6):466-69.
- Suga Y, Ogawa H. Sarcoidosis of the skin. J Journ Clin Med 1994;52(6):1603-07.
- Mert A, Ozaras R, Tabak F, et al. Erythema nodosum: an experience of 10 years. Scand J Infect Dis 2004;36(6-7):424-27.
- Bohn S, Buchner S, Itin P. Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr 1997;127(27-28):1168-76.
- Lin JT, Chen PM, Huang DF, et al. Erythema nodosum associated with carcinoid tumour. Clin Exp Dermatol 2004;29(4):426-27.
- Тареев Е.М., Корнев Б.М., Моисеев С.В. Узловатая эритема в клинике внутренних болезней // Тер. архив 1986. № 6. С. 36-39.
- Atanes A, Gomez N, Aspe B, et al. Erythema nodosum: a study of 160 cases. Med Clin (Barc) 1991;96:169-72.
- Requena L, Yus ES. Erythema nodosum. Dermatol Clin 2008;26(4):425-38.
- Mana J, Marcoval J, Graells J, et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 1997;133:882-28.
- Katta R. Cutaneous sarcoidosis. A dermatologic masquerader. Am Fam Physician 2002;65:1581-84.
- Yanardag H, Pamuk ON, Pamuk GE. Lupus pernio in sarcoidosis: clinical features and treatment outcomes of 14 patients. J Clin Rheumatol 2003;9(2):72-6.
- Spicknall K, English JC 3rd, Elston DM. Lupus pernio. Cutis 2007;79(4):289-90.
- Rosenberg B. Ichthyosiform sarcoisis. Dermatol Online J 2005;11(4):15.
- Sorabjee JS, Garje R. Reactivation of old scars: inevitably sarcoid. Postgrad Med J 2005;81(951):60-1.
- Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005;141(7):869-72.
- Katta R, Nelson B, Chen D, Roenigk H. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol 2000;42:690-92.
- Albertini JG, Tyler W, Miller OF. Ulcerative sarcoidosis. Case report and review of the literature. Arch Dermatol 1997;133:215-19.
- Tada Y, Kanda N, Ohnishi T, Watanabe S. Atypical cutaneous sarcoidosis with diffuse, indurated erythema. Eur J Dermatol 2009;19(6):639.
- Heinemann B. Uveitis with Brocq-Pautrier angiolupoid (Boeck disease of the skin). Klin Monbl Augenheilkd 1990;196(5):415-16.
- Marcoval J, Moreno A, Mana J, Peyri J. Subcutaneous sarcoidosis. Dermatol Clin 2008;26(4):553-56.
- Bosnic D, Baresic M, Bagatin D, Ilic I. Subcutaneous sarcoidosis of the face. Intern Med 2010;49(6):589-92.
- Marcoval J, Mana J, Moreno A, Peyri J. Subcutaneous sarcoidosis - сlinicopathological study of 10 cases. Br J Dermatol 2005;153(4):790-94.
- Resnik KS. Subcutaneous sarcoidosis histopathologically manifested as fibrosing granulomatous panniculitis. J Am Acad Dermatol 2006;55(5):918-19.
- Zic JA, Horowitz DH, Arzubiaga C, King LE. Treatmentof cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991;127:1034-40.
- Lee JB, Koblenzer PS. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report. J Am Acad Dermatol 1998;39(5 pt 2):835-38.
- Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991;24:451-54.
- Ramos-Casals M, Brito-Zeron P, Munoz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 2007;86(4):242-51.
- Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-4.
- Roberts SD, Wilkes DS, Burgett RA, Knox KS. Refractory sarcoidosis responding to infliximab. Chest 2003;124(5):2028-31.
- Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond) 2007;112(5):281-89.
- Thielen AM, Barde C, Saurat JH, Laffitte E. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists. Dermatology 2009;219(1):59-62.
- Cliff S, Felix RH, Singh L, Harland CC. The successful treatment of lupus pernio with the flashlamp pulsed dye laser. J Cutan Laser Ther 1999;1(1):49-52.
- Patterson C. Successful treatment of cutaneous sarcoid by photodynamic therapy with minimal discomfort using a fractionated dosing regime. Photodermatol Photoimmunol Photomed 2009;25(5):276-77.
Supplementary files
![](/img/style/loading.gif)